111 Capital’s Labcorp LH Stock Holding History

111 Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,685	Closed	-$392K	–	613
2025 Q1	$392K	Buy	+1,685	New	+$409K	0.08%	267

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

111 Capital's LH Position: Q2 2025 in Review

111 Capital sold out of Labcorp (LH) in Q2 2025, closing a stake of 1,685 shares — an estimated $392K sold.

111 Capital first reported a position in LH in Q1 2025 and held it in 1 quarter. The position peaked at $392K in Q1 2025. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

111 Capital reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
111 Capital sold 1,685 Labcorp shares in Q2 2025, an estimated $392K.
111 Capital first reported a position in Labcorp in Q1 2025 and held it in 1 quarter.
111 Capital's Labcorp position peaked at $392K in Q1 2025.
973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on 111 Capital's 13F filing for Q2 2025, filed 21 Jul 2025.